@misc{indiciae6ff778f646c5,
  title = {Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution compared to standard antibodies},
  author = {Khoury, N. and Pizzo, M. E. and Discenza, C. B. and Joy, D. and Tatarakis, D. and Todorov, M. I. and Negwer, M. and Ha, C. and De Melo, G. L. and Sarrafha, L. and Simon, M. J. and Chan, D. and Chau, R. and Chew, K. and Chow, J. and Clemens, A. and Robles-Colmenares, Y. and Dugas, J. C. and Duque, J. and Kaltenecker, D. and Kane, H. and Leung, A. and Lozano, E. and Moshkforoush, A. and Roche, E. and Sandmann, T. and Tong, M. and Xa, K. and Zhou, Y. and Lewcock, J. W. and Erturk, A. and Thorne, R. G. and Calvert, M. E. K. and Zuchero, Y. J. Y.},
  year = {2024},
  doi = {10.1101/2024.07.11.602993},
  url = {https://www.biorxiv.org/content/10.1101/2024.07.11.602993v1},
  note = {Source identifier: 10.1101/2024.07.11.602993}
}